CanSinoBIO Says COVID-19 Shot May Be Less Effective Over Time, Booster Shot Promising
BEIJING (Reuters) – China’s CanSino Biologics Inc said the efficacy rate for its single-dose COVID-19 vaccine may fall over time
Read moreBEIJING (Reuters) – China’s CanSino Biologics Inc said the efficacy rate for its single-dose COVID-19 vaccine may fall over time
Read moreROME (Reuters) – When alarm about potential side effects of AstraZeneca’s COVID-19 shot halted vaccinations around Europe this month, many
Read more(Reuters) – The human immune system makes many antibodies in response to COVID-19 infection or vaccination, and no single variant
Read moreHAVANA (Reuters) – Cuba’s drug regulatory authority on Thursday approved a second COVID-19 vaccine candidate for late-stage clinical trials as
Read moreBRUSSELS (Reuters) – The European Union’s executive will propose next week that new COVID-19 certificates combine information on vaccination, recovery
Read moreROME (Reuters) – Life expectancy in Italy fell by almost a year in 2020 due to the COVID-19 pandemic, national
Read moreNEW YORK (Reuters Health) – Children having surgery at Children’s Hospital of Philadelphia (CHOP) are required to have a reverse
Read more(Reuters) – Telehealth company Ro said on Wednesday it was partnering with New York state’s department of health to vaccinate
Read moreNEW YORK (Reuters Health) – With strict infection-control protocols, surfaces in outpatient and inpatient hematology/oncology settings are unlikely to be
Read moreBRUSSELS (Reuters) – The European Commission said on Tuesday that it was considering emergency approvals for COVID-19 vaccines as a
Read more